Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non-clear cell renal cell carcinoma: Real-world data from a Japanese multicenter retrospective study.

Keita Izumi Masaharu Inoue Satoshi WashinoSuguru ShirotakeMakoto KagawaHideki TakeshitaYuji MiuraYoji HyodoMasafumi OyamaSatoru KawakamiTomoaki MiyagawaKazutaka SaitoYukio Kageyama

Published in: International journal of urology : official journal of the Japanese Urological Association (2022)

Combination treatment with nivolumab and ipilimumab demonstrated modest clinical efficacy in patients with nccRCC compared with patients with ccRCC, suggesting it could be a therapeutic option for metastatic nccRCC patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
small cell lung cancer
squamous cell carcinoma
chronic kidney disease
peritoneal dialysis
electronic health record
clinical trial
big data
machine learning
artificial intelligence